| Primary |
| Multiple Myeloma |
25.5% |
| Product Used For Unknown Indication |
16.0% |
| Metastases To Bone |
13.2% |
| Breast Cancer |
10.2% |
| Osteoporosis |
7.0% |
| Osteolysis |
4.7% |
| Hypercalcaemia |
4.0% |
| Drug Use For Unknown Indication |
3.5% |
| Osteogenesis Imperfecta |
2.9% |
| Breast Cancer Metastatic |
2.2% |
| Hypercalcaemia Of Malignancy |
1.6% |
| Prostate Cancer |
1.6% |
| Osteitis Deformans |
1.4% |
| Metastasis |
1.2% |
| Pain |
1.0% |
| Complex Regional Pain Syndrome |
0.9% |
| Analgesic Therapy |
0.8% |
| Bone Pain |
0.8% |
| Neoplasm Malignant |
0.8% |
| Acute Lymphocytic Leukaemia |
0.7% |
|
| Pain |
32.1% |
| Osteonecrosis |
24.9% |
| Tooth Extraction |
10.0% |
| Osteonecrosis Of Jaw |
9.7% |
| Pain In Jaw |
2.4% |
| Nephrocalcinosis |
2.1% |
| Wound Debridement |
2.1% |
| Weight Decreased |
1.7% |
| Wound Dehiscence |
1.7% |
| Femur Fracture |
1.6% |
| Pyrexia |
1.6% |
| Wound Closure |
1.6% |
| Surgery |
1.3% |
| Wound Treatment |
1.3% |
| Ulcer |
1.1% |
| Anhedonia |
1.0% |
| Bone Disorder |
1.0% |
| Sequestrectomy |
1.0% |
| Stress Fracture |
1.0% |
| Toothache |
1.0% |
|
| Secondary |
| Multiple Myeloma |
29.3% |
| Metastases To Bone |
12.2% |
| Drug Use For Unknown Indication |
7.9% |
| Breast Cancer |
7.0% |
| Osteoporosis |
6.4% |
| Product Used For Unknown Indication |
4.7% |
| Pain |
4.1% |
| Seasonal Allergy |
3.2% |
| Stem Cell Transplant |
3.1% |
| Hypercalcaemia |
2.9% |
| Breast Cancer Metastatic |
2.7% |
| Prostate Cancer |
2.5% |
| Hypertension |
2.1% |
| Constipation |
2.0% |
| Osteogenesis Imperfecta |
1.9% |
| Depression |
1.7% |
| Hypercalcaemia Of Malignancy |
1.7% |
| Antiallergic Therapy |
1.5% |
| Hypokalaemia |
1.5% |
| Oedema |
1.5% |
|
| Osteonecrosis |
24.3% |
| Osteonecrosis Of Jaw |
12.0% |
| Tooth Extraction |
10.6% |
| Urinary Tract Infection |
7.0% |
| Pyrexia |
5.6% |
| Weight Decreased |
5.3% |
| Wound Dehiscence |
5.3% |
| Pain |
3.7% |
| Vomiting |
3.7% |
| Stress Fracture |
3.0% |
| Febrile Neutropenia |
2.7% |
| Glomerulonephritis Minimal Lesion |
2.7% |
| Pain In Jaw |
2.3% |
| Toothache |
2.3% |
| Hypercalcaemia |
2.0% |
| Surgery |
2.0% |
| Wound Infection Staphylococcal |
1.7% |
| Blood Immunoglobulin A Increased |
1.3% |
| Erythema Multiforme |
1.3% |
| Exposed Bone In Jaw |
1.3% |
|
| Concomitant |
| Multiple Myeloma |
25.0% |
| Drug Use For Unknown Indication |
21.5% |
| Product Used For Unknown Indication |
10.5% |
| Prophylaxis |
6.5% |
| Pain |
5.1% |
| Hypertension |
5.1% |
| Rheumatoid Arthritis |
3.2% |
| Constipation |
3.0% |
| Breast Cancer Metastatic |
2.4% |
| Back Pain |
2.1% |
| Osteoporosis |
2.0% |
| Nausea |
2.0% |
| Thrombosis Prophylaxis |
1.9% |
| Breast Cancer |
1.9% |
| Metastases To Bone |
1.4% |
| Non-small Cell Lung Cancer |
1.4% |
| Routine Health Maintenance |
1.4% |
| Supplementation Therapy |
1.4% |
| Bone Pain |
1.3% |
| Anxiety |
1.0% |
|
| Blood Human Chorionic Gonadotropin Increased |
9.7% |
| Thrombocytopenia |
9.7% |
| Sepsis |
8.3% |
| Death |
6.7% |
| Pneumonia |
6.3% |
| Multiple Myeloma |
6.0% |
| Pregnancy Test Positive |
5.0% |
| Syncope |
4.7% |
| Vomiting |
4.7% |
| White Blood Cell Count Decreased |
4.7% |
| Diarrhoea |
4.3% |
| Weight Decreased |
4.0% |
| Rash |
3.7% |
| Pulmonary Embolism |
3.3% |
| Renal Failure |
3.3% |
| Stomatitis |
3.3% |
| Vision Blurred |
3.3% |
| Wound Drainage |
3.3% |
| Wound Secretion |
3.0% |
| Osmotic Demyelination Syndrome |
2.7% |
|
| Interacting |
| Breast Cancer |
24.0% |
| Metastases To Bone |
16.0% |
| Breast Cancer Metastatic |
14.0% |
| Metastasis |
12.0% |
| Osteoporosis |
12.0% |
| Open Angle Glaucoma |
8.0% |
| Hypertension |
6.0% |
| Metastases To Pleura |
6.0% |
| Pain |
2.0% |
|
| Osteonecrosis |
33.3% |
| Swelling |
22.2% |
| Visual Acuity Reduced |
22.2% |
| Iridocyclitis |
11.1% |
| No Adverse Event |
11.1% |
|
